KPMG’s new report examines the growing trend of consolidation within the CRO industry and how that impacts health care and life sciences companies
In the UK, pharmaceutical companies have launched “money back guarantees” for expensive treatments of rare diseases. With this new setup, drug companies are responsible for high success rates of certain treatments for rare medical illnesses. If the drug does not live up to what it claims to do, then pharmaceutical companies are responsible for all […]
Since the early 1990s, there has been a sharp decline of FDA approvals for antibiotics, as pharmaceutical companies ceased antibody development due to high costs and low returns. However, with numerous government incentives for fighting antimicrobial resistance, companies are beginning to renew interest in the field. A May-June survey of 18 biotechnology, pharmaceutical and diagnostics […]
It was a challenging year for many publicly held contract testing lab companies, which provide a variety of analytical testing as well as other services across a range of industries. With networks of labs worldwide and extensive testing capabilities, such companies are major customers for analytical instrumentation and lab products. Their acquisition activities, lab expansions […]
As pharmaceutical companies expand their presence in emerging regions’ middle-class markets, they are incorporating new categories of products, including large-molecule biologics (i.e., monoclonal antibodies), and new gene and cell therapies. The biologics market is forecast to jump to $278 billion by 2020, a 71.6% increase from 2014. According to a survey of 254 pharmaceutical executives, […]
Pay Invoice
Latest Blogs
-
Lab Instrument Sales in China Collapse
March 29, 2024 1:15 pm
-
Pittcon 2024 Comes to San Diego
February 14, 2024 1:10 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
